mGem: A quarter century with the Pirofski-Casadevall damage response framework-a dynamic construct for understanding microbial pathogenesis
- PMID: 39932289
- PMCID: PMC11898690
- DOI: 10.1128/mbio.02945-24
mGem: A quarter century with the Pirofski-Casadevall damage response framework-a dynamic construct for understanding microbial pathogenesis
Abstract
A quarter of a century ago, Liise-anne Pirofski and Arturo Casadevall shared their concepts of microbial pathogenesis through the lens of a damage-response framework (DRF), which characterizes disease by assessing the dynamic interactions between the host and pathogen as reflected by damage as the readout. This framework has evolved to be a powerful tool for understanding the biology of complex infectious diseases, analyzing emerging and reemerging microbes, and developing therapeutic approaches to combat infections. The DRF is also frequently used to explain research at scientific meetings and to teach microbial pathogenesis to diverse learners. This mGem reviews how the DRF came to be and provides an overview of how it is used. Without a doubt, the scientific community will continue to leverage the DRF to advance research and innovate therapeutic approaches, which is especially important as new and reemerging infectious diseases threaten global health.
Keywords: education; microbial pathogenesis; scientific framework.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Ullmann A. 2007. Pasteur-Koch: distinctive ways of thinking about infectious diseases, p 383–387. In Microbe. Vol. 2.
-
- WHO . 2022. WHO fungal priority pathogens list to guide research, development and public health action. World Heath Organization, Geneva, Switzerland.
-
- Loeffler F. 1884. Untersuchungen über die Bedeutung der Mikroorganismen für die Entstehung der Diptherie beim Menschen, bei der Taube und beim Kalbe. Mitth. a.d. kaiserl, p 421–499. In Gesundheitsampte Ii. Mitth ad kaiserl Gesundheitsampte Ii.
Publication types
MeSH terms
Grants and funding
- R21 AI156104/AI/NIAID NIH HHS/United States
- AI171093/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- AI156104/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R01 AI171093/AI/NIAID NIH HHS/United States
- AI183314/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
LinkOut - more resources
Full Text Sources
Medical